North East and North Cumbria
ICS Formulary
ICS Formulary
2 Cardiovascular system
02-06-03 Other anitanginal drugs
| Nicorandil |
|
Formulary
|
 MHRA Drug Safety Update (Jan 2016): Nicorandil (Ikorel): now second-line treatment for angina - risk of ulcer complications |
|
| Ivabradine |
|
Formulary
|
|
|
NICE CG126: Guidance on Stable Angina (2011) MHRA Drug Safety Update (Dec 2014): Ivabradine (Procoralan) in the symptomatic treatment of angina: risk of cardiac side effects NICE TA267: Ivabradine for treating chronic heart failure |
|
| Ranolazine |
|
Formulary
|
|
|
NICE CG126: Guidance on Stable Angina (2011) |
|
|
Links
- Academic Health Science Network (North East and North Cumbria) - Atrial Fibrilation
- County Durham and Darlington DVT Pathway Information
- MHRA Drug Safety Update (Dec 2014): Ivabradine (Procoralan) in the symptomatic treatment of angina: risk of cardiac side effects
- MHRA Drug Safety Update (Jan 2016): Nicorandil (Ikorel): now second-line treatment for angina - risk of ulcer complications
- NICE CG126: Guidance on Stable Angina (2011)
- NICE CG126: Guidance on Stable Angina (2011)
- NICE NG148: Acute kidney injury: prevention, detection and management
- NICE NG191: COVID-19 rapid guideline: managing COVID-19
- NICE TA267: Ivabradine for treating chronic heart failure
North of Tyne, Gateshead and North Cumbria - Management of angina due to coronary artery disease- South Tees Hospitals Cardiology drug prescribing guidelines & formulary